Gianluigi Savarese

Gianluigi Savarese

Karolinska Institute, Stockholm, Sweden

  • LinkedIn
  • X

Media

HFA 2020: Eligibility for sacubitril/valsartan in HF across the EF spectrum

Gianluigi Savarese,

Watch time: 7m 56s
image

Gianluigi Savarese,

Articles by Gianluigi Savarese

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?

Gianluigi Savarese,

Citation: European Cardiology Review 2019;14(3):139–40

DOI:

https://doi.org/10.15420/ecr.2019.14.3.GE3
Global Public Health Burden of Heart Failure

Gianluigi Savarese, Lars H Lund,

Citation: Cardiac Failure Review 2017;3(1):7–11.

DOI:

https://doi.org/10.15420/cfr.2016:25:2
Use of Renin–Angiotensin–Aldosterone System Inhibitors in Older Patients with Heart Failure and Reduced Ejection Fraction

Davide Stolfo, Gianluigi Savarese,

Citation: Cardiac Failure Review 2019;5(2):70–3.

DOI:

https://doi.org/10.15420/cfr.2019.6.2